AnodeAI/Medical_genomics · Datasets at Hugging Face

patient_id stringlengths 12 12	record_id stringlengths 11 11	cancer_type stringclasses 1 value	histology stringclasses 3 values	stage_at_diagnosis stringclasses 3 values	driver_mutation stringclasses 7 values	pd_l1_tps_percent int64 5 41	tmb_mutations_per_mb float64 1.5 25	age_at_diagnosis int64 38 90	sex stringclasses 2 values	ecog_performance_status int64 0 4	smoking_pack_years int64 0 111	primary_tumor_size_cm float64 2 10	metastatic_sites_count int64 0 11	first_line_regimen stringclasses 6 values	overall_survival_months float64 4 83	censored bool 2 classes	msi_status stringclasses 2 values	record_generation_timestamp stringdate 2026-03-15 05:35:56 2026-03-15 05:36:02	synthetic_source stringclasses 1 value
ANODE_760095	REC_0009101	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	33	8.3	74	female	0	7	4.6	5	sotorasib 960 mg daily	17.3	false	MSS	2026-03-15T05:35:59.100313+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_787826	REC_0009102	Non-small cell lung cancer	Adenocarcinoma	IVA	ROS1 fusion	23	14.7	67	male	0	8	6	2	entrectinib 600 mg daily	23.7	false	MSS	2026-03-15T05:35:59.100557+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_170951	REC_0009103	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	28	14.2	65	male	0	2	6.2	5	alectinib 600 mg BID	9.3	true	MSS	2026-03-15T05:35:59.100795+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_586419	REC_0009104	Non-small cell lung cancer	Squamous cell carcinoma	III	None	22	3.2	68	male	1	46	5.8	0	carboplatin + paclitaxel + pembrolizumab	50.9	true	MSS	2026-03-15T05:35:59.101030+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_160446	REC_0009105	Non-small cell lung cancer	Large cell carcinoma	IVB	None (PD-L1 high)	29	4.8	51	female	0	16	4.9	5	pembrolizumab 200 mg q3w	4	false	MSS	2026-03-15T05:35:59.101263+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_528033	REC_0009106	Non-small cell lung cancer	Adenocarcinoma	IVA	KRAS G12C	23	10.3	63	female	0	16	6.2	1	sotorasib 960 mg daily	16.4	false	MSS	2026-03-15T05:35:59.101497+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_339607	REC_0009107	Non-small cell lung cancer	Squamous cell carcinoma	IVA	None (PD-L1 high)	23	6	63	male	0	47	6.2	2	pembrolizumab 200 mg q3w	21.8	false	MSS	2026-03-15T05:35:59.101731+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_447559	REC_0009108	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	22	15	65	male	0	12	6.1	7	entrectinib 600 mg daily	12.2	true	MSI-H	2026-03-15T05:35:59.101966+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_701765	REC_0009109	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	26	4.1	60	female	0	62	4	7	carboplatin + paclitaxel + pembrolizumab	7.4	false	MSS	2026-03-15T05:35:59.102196+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_519013	REC_0009110	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR exon 19 deletion	23	15.3	68	female	0	12	4.9	2	osimertinib 80 mg daily	9.3	true	MSS	2026-03-15T05:35:59.102433+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_999944	REC_0009111	Non-small cell lung cancer	Adenocarcinoma	IVB	None (PD-L1 high)	29	7.9	67	female	0	13	6.4	7	pembrolizumab 200 mg q3w	14.4	true	MSS	2026-03-15T05:35:59.102663+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_540185	REC_0009112	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	33	13.7	71	male	2	10	3.6	6	alectinib 600 mg BID	6.3	true	MSS	2026-03-15T05:35:59.102899+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_840176	REC_0009113	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	30	6.1	61	female	1	41	5.2	3	carboplatin + paclitaxel + pembrolizumab	17.9	false	MSS	2026-03-15T05:35:59.103131+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_789917	REC_0009114	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR L858R	22	9.9	72	female	1	20	5.3	2	osimertinib 80 mg daily	16.1	false	MSS	2026-03-15T05:35:59.103406+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_362570	REC_0009115	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	22	9.6	66	male	1	11	4.9	6	osimertinib 80 mg daily	7.4	false	MSS	2026-03-15T05:35:59.103642+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_318341	REC_0009116	Non-small cell lung cancer	Large cell carcinoma	IVB	None (PD-L1 high)	25	5.2	66	female	0	10	6.6	5	pembrolizumab 200 mg q3w	7	false	MSS	2026-03-15T05:35:59.103872+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_586445	REC_0009117	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	27	12.8	71	female	2	14	4.1	6	osimertinib 80 mg daily	17.6	true	MSS	2026-03-15T05:35:59.104160+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_265141	REC_0009118	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	29	17.9	69	male	0	12	5.1	4	entrectinib 600 mg daily	13.5	false	MSS	2026-03-15T05:35:59.104413+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_793776	REC_0009119	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR exon 19 deletion	23	6.2	75	female	1	13	6.7	9	osimertinib 80 mg daily	11.7	false	MSS	2026-03-15T05:35:59.104649+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_519573	REC_0009120	Non-small cell lung cancer	Adenocarcinoma	IVA	ALK fusion	26	11.3	59	male	1	22	3.9	1	alectinib 600 mg BID	8.4	false	MSS	2026-03-15T05:35:59.104885+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_981187	REC_0009121	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	20	17.1	73	male	2	17	8	6	entrectinib 600 mg daily	7.8	true	MSI-H	2026-03-15T05:35:59.105131+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_273597	REC_0009122	Non-small cell lung cancer	Adenocarcinoma	III	KRAS G12C	35	14.9	67	female	0	13	4.8	0	sotorasib 960 mg daily	28.6	true	MSS	2026-03-15T05:35:59.105380+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_505661	REC_0009123	Non-small cell lung cancer	Adenocarcinoma	III	EGFR L858R	29	7.6	79	male	1	26	5.4	0	osimertinib 80 mg daily	50.1	false	MSS	2026-03-15T05:35:59.105619+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_916723	REC_0009124	Non-small cell lung cancer	Large cell carcinoma	IVA	None (PD-L1 high)	21	11.2	79	male	2	16	6.2	2	pembrolizumab 200 mg q3w	11.5	false	MSS	2026-03-15T05:35:59.105855+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_323297	REC_0009125	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	20	15.9	53	male	0	22	5.7	5	osimertinib 80 mg daily	13.8	true	MSS	2026-03-15T05:35:59.106096+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_610724	REC_0009126	Non-small cell lung cancer	Adenocarcinoma	IVA	KRAS G12C	24	13.4	63	male	0	14	3.6	1	sotorasib 960 mg daily	14.3	false	MSS	2026-03-15T05:35:59.106336+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_597134	REC_0009127	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR exon 19 deletion	16	8.3	78	female	1	14	5.6	5	osimertinib 80 mg daily	10.5	false	MSS	2026-03-15T05:35:59.106643+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_132400	REC_0009128	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR exon 19 deletion	25	9	61	female	0	11	2.2	5	osimertinib 80 mg daily	8.5	true	MSS	2026-03-15T05:35:59.106894+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_377047	REC_0009129	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	24	7.5	69	female	1	41	6.5	5	carboplatin + paclitaxel + pembrolizumab	12.4	false	MSS	2026-03-15T05:35:59.107135+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_262777	REC_0009130	Non-small cell lung cancer	Squamous cell carcinoma	III	None	30	5.3	68	female	0	42	5.6	0	carboplatin + paclitaxel + pembrolizumab	13.4	true	MSS	2026-03-15T05:35:59.107378+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_213177	REC_0009131	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	29	8.9	66	female	0	14	5.3	5	osimertinib 80 mg daily	14.2	false	MSS	2026-03-15T05:35:59.107631+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_556028	REC_0009132	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR exon 19 deletion	25	14.7	78	female	1	9	4.7	6	osimertinib 80 mg daily	13	false	MSS	2026-03-15T05:35:59.107879+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_113290	REC_0009133	Non-small cell lung cancer	Adenocarcinoma	IVA	ALK fusion	16	11.2	48	male	0	13	4.3	1	alectinib 600 mg BID	10.2	false	MSI-H	2026-03-15T05:35:59.108206+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_161148	REC_0009134	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	24	12.3	64	female	1	11	5.2	3	osimertinib 80 mg daily	19.4	true	MSI-H	2026-03-15T05:35:59.108478+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_498792	REC_0009135	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	36	12.4	75	female	1	2	5.1	4	alectinib 600 mg BID	9.4	false	MSS	2026-03-15T05:35:59.108730+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_502184	REC_0009136	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	35	5.7	65	male	0	52	3.1	7	carboplatin + paclitaxel + pembrolizumab	16.5	true	MSS	2026-03-15T05:35:59.108971+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_195620	REC_0009137	Non-small cell lung cancer	Large cell carcinoma	IVB	None (PD-L1 high)	27	5.2	65	female	0	18	5.1	4	pembrolizumab 200 mg q3w	14.9	true	MSS	2026-03-15T05:35:59.109215+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_673456	REC_0009138	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	24	2.9	65	female	1	42	5.6	4	carboplatin + paclitaxel + pembrolizumab	7.1	true	MSS	2026-03-15T05:35:59.109459+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_837746	REC_0009139	Non-small cell lung cancer	Adenocarcinoma	IVA	ROS1 fusion	22	11.3	61	male	1	19	4.8	1	entrectinib 600 mg daily	19.7	false	MSI-H	2026-03-15T05:35:59.109702+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_614089	REC_0009140	Non-small cell lung cancer	Adenocarcinoma	IVA	ALK fusion	19	9.2	74	female	2	14	4.1	2	alectinib 600 mg BID	12.2	false	MSS	2026-03-15T05:35:59.110061+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_509763	REC_0009141	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	23	10.5	82	male	2	9	8.1	4	alectinib 600 mg BID	13.7	true	MSS	2026-03-15T05:35:59.110314+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_161975	REC_0009142	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR exon 19 deletion	20	14.4	68	female	0	28	5.3	7	osimertinib 80 mg daily	8.2	true	MSS	2026-03-15T05:35:59.110552+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_532402	REC_0009143	Non-small cell lung cancer	Squamous cell carcinoma	IVA	None	25	5	73	female	3	36	4.7	2	carboplatin + paclitaxel + pembrolizumab	19.3	false	MSS	2026-03-15T05:35:59.110796+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_244723	REC_0009144	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR exon 19 deletion	24	9.9	67	female	0	5	5.5	2	osimertinib 80 mg daily	24	true	MSS	2026-03-15T05:35:59.111034+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_279316	REC_0009145	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	21	9.8	70	female	3	23	4.3	6	alectinib 600 mg BID	16.3	true	MSS	2026-03-15T05:35:59.111265+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_356552	REC_0009146	Non-small cell lung cancer	Adenocarcinoma	IVA	ALK fusion	28	14.6	72	female	2	4	7.5	0	alectinib 600 mg BID	22.2	false	MSI-H	2026-03-15T05:35:59.111510+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_986064	REC_0009147	Non-small cell lung cancer	Adenocarcinoma	IVA	KRAS G12C	23	16.9	55	male	1	17	4.6	2	sotorasib 960 mg daily	15.6	false	MSS	2026-03-15T05:35:59.111749+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_280848	REC_0009148	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	21	17.2	66	female	1	9	5.4	3	osimertinib 80 mg daily	8.2	true	MSI-H	2026-03-15T05:35:59.111986+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_948734	REC_0009149	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	25	16.7	73	female	1	14	6.5	6	sotorasib 960 mg daily	9.7	false	MSS	2026-03-15T05:35:59.112269+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_674017	REC_0009150	Non-small cell lung cancer	Large cell carcinoma	IVB	None (PD-L1 high)	21	4.7	56	female	1	20	6.3	4	pembrolizumab 200 mg q3w	17.7	true	MSS	2026-03-15T05:35:59.112509+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_282664	REC_0009151	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	19	11.7	63	female	1	6	5.7	5	sotorasib 960 mg daily	11	false	MSS	2026-03-15T05:35:59.112758+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_970529	REC_0009152	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	18	9.1	73	female	1	12	4.6	6	osimertinib 80 mg daily	4	true	MSS	2026-03-15T05:35:59.112994+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_545277	REC_0009153	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None (PD-L1 high)	31	5.3	42	male	0	57	5	6	pembrolizumab 200 mg q3w	11.4	false	MSS	2026-03-15T05:35:59.113372+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_684735	REC_0009154	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	27	4.8	60	male	0	9	4.8	6	sotorasib 960 mg daily	11.5	false	MSS	2026-03-15T05:35:59.113629+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_594716	REC_0009155	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None	25	4.7	68	female	0	67	5	6	carboplatin + paclitaxel + pembrolizumab	13.3	false	MSS	2026-03-15T05:35:59.113862+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_535230	REC_0009156	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	31	4.5	59	male	1	11	5.4	6	osimertinib 80 mg daily	18.2	false	MSS	2026-03-15T05:35:59.114108+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_287509	REC_0009157	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR exon 19 deletion	28	7.7	67	female	1	3	5.9	2	osimertinib 80 mg daily	16.6	true	MSS	2026-03-15T05:35:59.114347+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_973602	REC_0009158	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	19	19.4	70	male	2	20	5.8	5	alectinib 600 mg BID	11.9	false	MSI-H	2026-03-15T05:35:59.114597+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_952640	REC_0009159	Non-small cell lung cancer	Adenocarcinoma	IVA	KRAS G12C	19	15.7	61	female	1	12	4.9	2	sotorasib 960 mg daily	34.8	false	MSS	2026-03-15T05:35:59.114852+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_379377	REC_0009160	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	20	13.8	65	male	0	20	6	4	osimertinib 80 mg daily	8.3	false	MSI-H	2026-03-15T05:35:59.115097+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_386745	REC_0009161	Non-small cell lung cancer	Adenocarcinoma	IVA	ROS1 fusion	28	5.5	63	female	0	18	3.9	1	entrectinib 600 mg daily	15.4	false	MSS	2026-03-15T05:35:59.115346+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_703109	REC_0009162	Non-small cell lung cancer	Adenocarcinoma	III	EGFR exon 19 deletion	22	11.4	77	female	3	14	5	0	osimertinib 80 mg daily	19.2	false	MSI-H	2026-03-15T05:35:59.115591+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_242857	REC_0009163	Non-small cell lung cancer	Adenocarcinoma	IVA	ROS1 fusion	26	14	63	male	1	28	5.7	2	entrectinib 600 mg daily	12.2	false	MSS	2026-03-15T05:35:59.115833+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_529230	REC_0009164	Non-small cell lung cancer	Adenocarcinoma	IVA	ROS1 fusion	28	12.9	71	female	1	20	6.7	2	entrectinib 600 mg daily	20.1	false	MSI-H	2026-03-15T05:35:59.116125+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_775751	REC_0009165	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR L858R	29	10.3	75	female	1	10	5.9	8	osimertinib 80 mg daily	5.9	true	MSI-H	2026-03-15T05:35:59.116381+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_359261	REC_0009166	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	18	5.8	66	female	0	16	5.4	5	sotorasib 960 mg daily	10	true	MSS	2026-03-15T05:35:59.116745+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_187311	REC_0009167	Non-small cell lung cancer	Adenocarcinoma	IVA	ALK fusion	17	16.7	65	male	0	4	6.4	2	alectinib 600 mg BID	11.3	false	MSI-H	2026-03-15T05:35:59.116995+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_824359	REC_0009168	Non-small cell lung cancer	Large cell carcinoma	IVA	None (PD-L1 high)	20	5.4	69	male	0	14	6.2	1	pembrolizumab 200 mg q3w	18.6	false	MSS	2026-03-15T05:35:59.117234+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_926704	REC_0009169	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR exon 19 deletion	21	15	73	female	2	17	4.8	1	osimertinib 80 mg daily	20.2	false	MSI-H	2026-03-15T05:35:59.117487+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_292031	REC_0009170	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	18	16.2	72	female	2	21	5.6	7	entrectinib 600 mg daily	4.1	true	MSS	2026-03-15T05:35:59.117730+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_392599	REC_0009171	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	29	18.7	67	female	0	4	4.5	5	entrectinib 600 mg daily	6	true	MSS	2026-03-15T05:35:59.117973+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_625225	REC_0009172	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	31	13.4	86	male	1	6	5.7	4	sotorasib 960 mg daily	13.5	true	MSS	2026-03-15T05:35:59.118213+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_927470	REC_0009173	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	25	12.8	68	female	0	16	4.4	8	sotorasib 960 mg daily	13.3	true	MSI-H	2026-03-15T05:35:59.118448+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_967024	REC_0009174	Non-small cell lung cancer	Adenocarcinoma	IVB	None (PD-L1 high)	32	8.8	75	female	2	16	5.6	5	pembrolizumab 200 mg q3w	9.2	false	MSS	2026-03-15T05:35:59.118676+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_337319	REC_0009175	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR L858R	26	15.1	67	male	0	18	6.1	2	osimertinib 80 mg daily	20.6	true	MSS	2026-03-15T05:35:59.118919+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_902198	REC_0009176	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR L858R	29	4	73	female	2	24	6.5	2	osimertinib 80 mg daily	19.5	true	MSS	2026-03-15T05:35:59.119157+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_591818	REC_0009177	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	24	13.7	75	female	1	12	5.5	5	sotorasib 960 mg daily	13.5	false	MSS	2026-03-15T05:35:59.119396+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_399930	REC_0009178	Non-small cell lung cancer	Adenocarcinoma	IVA	ALK fusion	20	10.9	67	female	0	19	6	2	alectinib 600 mg BID	25.4	true	MSI-H	2026-03-15T05:35:59.119635+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_352839	REC_0009179	Non-small cell lung cancer	Squamous cell carcinoma	IVB	None (PD-L1 high)	19	3.8	66	female	1	21	6.8	3	pembrolizumab 200 mg q3w	16.6	true	MSS	2026-03-15T05:35:59.119963+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_677324	REC_0009180	Non-small cell lung cancer	Adenocarcinoma	IVA	ROS1 fusion	26	7.3	77	female	2	19	5.4	2	entrectinib 600 mg daily	25	false	MSS	2026-03-15T05:35:59.120248+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_229694	REC_0009181	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	28	9.4	47	female	0	17	4	4	alectinib 600 mg BID	16	false	MSS	2026-03-15T05:35:59.120487+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_207632	REC_0009182	Non-small cell lung cancer	Adenocarcinoma	III	KRAS G12C	18	19	60	male	1	5	7.9	0	sotorasib 960 mg daily	35.3	false	MSI-H	2026-03-15T05:35:59.120722+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_823729	REC_0009183	Non-small cell lung cancer	Adenocarcinoma	IVA	EGFR exon 19 deletion	28	14.1	74	female	2	20	5.2	2	osimertinib 80 mg daily	9.3	false	MSI-H	2026-03-15T05:35:59.120956+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_514307	REC_0009184	Non-small cell lung cancer	Adenocarcinoma	IVB	EGFR exon 19 deletion	18	9.4	72	female	1	10	5.8	4	osimertinib 80 mg daily	6.9	false	MSS	2026-03-15T05:35:59.121196+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_897417	REC_0009185	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	24	12.5	73	female	3	21	4.6	5	sotorasib 960 mg daily	15.3	false	MSS	2026-03-15T05:35:59.121436+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_101132	REC_0009186	Non-small cell lung cancer	Adenocarcinoma	IVB	ALK fusion	19	12.5	68	female	1	22	5.4	9	alectinib 600 mg BID	11.6	false	MSS	2026-03-15T05:35:59.121669+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_280195	REC_0009187	Non-small cell lung cancer	Large cell carcinoma	IVB	None (PD-L1 high)	31	5.9	73	female	2	25	5.1	4	pembrolizumab 200 mg q3w	6.2	false	MSS	2026-03-15T05:35:59.121897+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_342946	REC_0009188	Non-small cell lung cancer	Squamous cell carcinoma	IVA	None	25	5.3	67	female	1	5	4.7	2	carboplatin + paclitaxel + pembrolizumab	16.3	false	MSS	2026-03-15T05:35:59.122131+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_661196	REC_0009189	Non-small cell lung cancer	Large cell carcinoma	IVB	None (PD-L1 high)	24	5.2	69	male	0	7	6.8	8	pembrolizumab 200 mg q3w	13.2	false	MSS	2026-03-15T05:35:59.122367+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_149255	REC_0009190	Non-small cell lung cancer	Adenocarcinoma	IVA	KRAS G12C	31	7.9	64	male	1	16	5.4	1	sotorasib 960 mg daily	22.4	false	MSS	2026-03-15T05:35:59.122601+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_328334	REC_0009191	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	20	13	64	female	1	13	5.7	5	sotorasib 960 mg daily	8.6	true	MSI-H	2026-03-15T05:35:59.122844+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_113033	REC_0009192	Non-small cell lung cancer	Adenocarcinoma	IVA	ALK fusion	34	4.9	58	male	0	17	5.4	1	alectinib 600 mg BID	28.3	false	MSS	2026-03-15T05:35:59.123159+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_604001	REC_0009193	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	22	10.6	67	female	0	18	4.2	8	entrectinib 600 mg daily	11.9	true	MSS	2026-03-15T05:35:59.123405+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_634434	REC_0009194	Non-small cell lung cancer	Adenocarcinoma	IVA	ROS1 fusion	24	4.5	61	male	1	13	4.2	2	entrectinib 600 mg daily	19.6	true	MSS	2026-03-15T05:35:59.123646+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_994807	REC_0009195	Non-small cell lung cancer	Adenocarcinoma	III	EGFR exon 19 deletion	28	15.3	57	female	1	23	7.4	0	osimertinib 80 mg daily	40.9	true	MSI-H	2026-03-15T05:35:59.123897+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_636650	REC_0009196	Non-small cell lung cancer	Adenocarcinoma	IVB	ROS1 fusion	31	13.2	68	male	0	11	6.1	6	entrectinib 600 mg daily	10.5	false	MSI-H	2026-03-15T05:35:59.124192+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_986416	REC_0009197	Non-small cell lung cancer	Large cell carcinoma	IVB	None (PD-L1 high)	21	4.9	64	female	1	4	6.1	8	pembrolizumab 200 mg q3w	12	false	MSS	2026-03-15T05:35:59.124458+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_475068	REC_0009198	Non-small cell lung cancer	Adenocarcinoma	IVB	None (PD-L1 high)	20	15.8	57	female	0	27	6.1	8	pembrolizumab 200 mg q3w	16.3	true	MSS	2026-03-15T05:35:59.124711+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_609313	REC_0009199	Non-small cell lung cancer	Adenocarcinoma	IVA	KRAS G12C	24	16.5	82	female	2	11	5.9	1	sotorasib 960 mg daily	22.9	true	MSS	2026-03-15T05:35:59.124953+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)
ANODE_452052	REC_0009200	Non-small cell lung cancer	Adenocarcinoma	IVB	KRAS G12C	22	14.7	77	male	2	21	6.7	6	sotorasib 960 mg daily	16.9	false	MSS	2026-03-15T05:35:59.125193+00:00	Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_760095

REC_0009101

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

33

8.3

74

female

0

7

4.6

5

sotorasib 960 mg daily

17.3

false

MSS

2026-03-15T05:35:59.100313+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_787826

REC_0009102

Non-small cell lung cancer

Adenocarcinoma

IVA

ROS1 fusion

23

14.7

67

male

0

8

6

2

entrectinib 600 mg daily

23.7

false

MSS

2026-03-15T05:35:59.100557+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_170951

REC_0009103

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

28

14.2

65

male

0

2

6.2

5

alectinib 600 mg BID

9.3

true

MSS

2026-03-15T05:35:59.100795+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_586419

REC_0009104

Non-small cell lung cancer

Squamous cell carcinoma

III

None

22

3.2

68

male

1

46

5.8

0

carboplatin + paclitaxel + pembrolizumab

50.9

true

MSS

2026-03-15T05:35:59.101030+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_160446

REC_0009105

Non-small cell lung cancer

Large cell carcinoma

IVB

None (PD-L1 high)

29

4.8

51

female

0

16

4.9

5

pembrolizumab 200 mg q3w

4

false

MSS

2026-03-15T05:35:59.101263+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_528033

REC_0009106

Non-small cell lung cancer

Adenocarcinoma

IVA

KRAS G12C

23

10.3

63

female

0

16

6.2

1

sotorasib 960 mg daily

16.4

false

MSS

2026-03-15T05:35:59.101497+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_339607

REC_0009107

Non-small cell lung cancer

Squamous cell carcinoma

IVA

None (PD-L1 high)

23

6

63

male

0

47

6.2

2

pembrolizumab 200 mg q3w

21.8

false

MSS

2026-03-15T05:35:59.101731+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_447559

REC_0009108

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

22

15

65

male

0

12

6.1

7

entrectinib 600 mg daily

12.2

true

MSI-H

2026-03-15T05:35:59.101966+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_701765

REC_0009109

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

26

4.1

60

female

0

62

4

7

carboplatin + paclitaxel + pembrolizumab

7.4

false

MSS

2026-03-15T05:35:59.102196+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_519013

REC_0009110

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR exon 19 deletion

23

15.3

68

female

0

12

4.9

2

osimertinib 80 mg daily

9.3

true

MSS

2026-03-15T05:35:59.102433+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_999944

REC_0009111

Non-small cell lung cancer

Adenocarcinoma

IVB

None (PD-L1 high)

29

7.9

67

female

0

13

6.4

7

pembrolizumab 200 mg q3w

14.4

true

MSS

2026-03-15T05:35:59.102663+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_540185

REC_0009112

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

33

13.7

71

male

2

10

3.6

6

alectinib 600 mg BID

6.3

true

MSS

2026-03-15T05:35:59.102899+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_840176

REC_0009113

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

30

6.1

61

female

1

41

5.2

3

carboplatin + paclitaxel + pembrolizumab

17.9

false

MSS

2026-03-15T05:35:59.103131+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_789917

REC_0009114

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR L858R

22

9.9

72

female

1

20

5.3

2

osimertinib 80 mg daily

16.1

false

MSS

2026-03-15T05:35:59.103406+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_362570

REC_0009115

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

22

9.6

66

male

1

11

4.9

6

osimertinib 80 mg daily

7.4

false

MSS

2026-03-15T05:35:59.103642+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_318341

REC_0009116

Non-small cell lung cancer

Large cell carcinoma

IVB

None (PD-L1 high)

25

5.2

66

female

0

10

6.6

5

pembrolizumab 200 mg q3w

7

false

MSS

2026-03-15T05:35:59.103872+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_586445

REC_0009117

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

27

12.8

71

female

2

14

4.1

6

osimertinib 80 mg daily

17.6

true

MSS

2026-03-15T05:35:59.104160+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_265141

REC_0009118

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

29

17.9

69

male

0

12

5.1

4

entrectinib 600 mg daily

13.5

false

MSS

2026-03-15T05:35:59.104413+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_793776

REC_0009119

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR exon 19 deletion

23

6.2

75

female

1

13

6.7

9

osimertinib 80 mg daily

11.7

false

MSS

2026-03-15T05:35:59.104649+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_519573

REC_0009120

Non-small cell lung cancer

Adenocarcinoma

IVA

ALK fusion

26

11.3

59

male

1

22

3.9

1

alectinib 600 mg BID

8.4

false

MSS

2026-03-15T05:35:59.104885+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_981187

REC_0009121

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

20

17.1

73

male

2

17

8

6

entrectinib 600 mg daily

7.8

true

MSI-H

2026-03-15T05:35:59.105131+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_273597

REC_0009122

Non-small cell lung cancer

Adenocarcinoma

III

KRAS G12C

35

14.9

67

female

0

13

4.8

0

sotorasib 960 mg daily

28.6

true

MSS

2026-03-15T05:35:59.105380+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_505661

REC_0009123

Non-small cell lung cancer

Adenocarcinoma

III

EGFR L858R

29

7.6

79

male

1

26

5.4

0

osimertinib 80 mg daily

50.1

false

MSS

2026-03-15T05:35:59.105619+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_916723

REC_0009124

Non-small cell lung cancer

Large cell carcinoma

IVA

None (PD-L1 high)

21

11.2

79

male

2

16

6.2

2

pembrolizumab 200 mg q3w

11.5

false

MSS

2026-03-15T05:35:59.105855+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_323297

REC_0009125

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

20

15.9

53

male

0

22

5.7

5

osimertinib 80 mg daily

13.8

true

MSS

2026-03-15T05:35:59.106096+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_610724

REC_0009126

Non-small cell lung cancer

Adenocarcinoma

IVA

KRAS G12C

24

13.4

63

male

0

14

3.6

1

sotorasib 960 mg daily

14.3

false

MSS

2026-03-15T05:35:59.106336+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_597134

REC_0009127

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR exon 19 deletion

16

8.3

78

female

1

14

5.6

5

osimertinib 80 mg daily

10.5

false

MSS

2026-03-15T05:35:59.106643+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_132400

REC_0009128

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR exon 19 deletion

25

9

61

female

0

11

2.2

5

osimertinib 80 mg daily

8.5

true

MSS

2026-03-15T05:35:59.106894+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_377047

REC_0009129

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

24

7.5

69

female

1

41

6.5

5

carboplatin + paclitaxel + pembrolizumab

12.4

false

MSS

2026-03-15T05:35:59.107135+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_262777

REC_0009130

Non-small cell lung cancer

Squamous cell carcinoma

III

None

30

5.3

68

female

0

42

5.6

0

carboplatin + paclitaxel + pembrolizumab

13.4

true

MSS

2026-03-15T05:35:59.107378+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_213177

REC_0009131

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

29

8.9

66

female

0

14

5.3

5

osimertinib 80 mg daily

14.2

false

MSS

2026-03-15T05:35:59.107631+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_556028

REC_0009132

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR exon 19 deletion

25

14.7

78

female

1

9

4.7

6

osimertinib 80 mg daily

13

false

MSS

2026-03-15T05:35:59.107879+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_113290

REC_0009133

Non-small cell lung cancer

Adenocarcinoma

IVA

ALK fusion

16

11.2

48

male

0

13

4.3

1

alectinib 600 mg BID

10.2

false

MSI-H

2026-03-15T05:35:59.108206+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_161148

REC_0009134

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

24

12.3

64

female

1

11

5.2

3

osimertinib 80 mg daily

19.4

true

MSI-H

2026-03-15T05:35:59.108478+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_498792

REC_0009135

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

36

12.4

75

female

1

2

5.1

4

alectinib 600 mg BID

9.4

false

MSS

2026-03-15T05:35:59.108730+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_502184

REC_0009136

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

35

5.7

65

male

0

52

3.1

7

carboplatin + paclitaxel + pembrolizumab

16.5

true

MSS

2026-03-15T05:35:59.108971+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_195620

REC_0009137

Non-small cell lung cancer

Large cell carcinoma

IVB

None (PD-L1 high)

27

5.2

65

female

0

18

5.1

4

pembrolizumab 200 mg q3w

14.9

true

MSS

2026-03-15T05:35:59.109215+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_673456

REC_0009138

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

24

2.9

65

female

1

42

5.6

4

carboplatin + paclitaxel + pembrolizumab

7.1

true

MSS

2026-03-15T05:35:59.109459+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_837746

REC_0009139

Non-small cell lung cancer

Adenocarcinoma

IVA

ROS1 fusion

22

11.3

61

male

1

19

4.8

1

entrectinib 600 mg daily

19.7

false

MSI-H

2026-03-15T05:35:59.109702+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_614089

REC_0009140

Non-small cell lung cancer

Adenocarcinoma

IVA

ALK fusion

19

9.2

74

female

2

14

4.1

2

alectinib 600 mg BID

12.2

false

MSS

2026-03-15T05:35:59.110061+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_509763

REC_0009141

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

23

10.5

82

male

2

9

8.1

4

alectinib 600 mg BID

13.7

true

MSS

2026-03-15T05:35:59.110314+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_161975

REC_0009142

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR exon 19 deletion

20

14.4

68

female

0

28

5.3

7

osimertinib 80 mg daily

8.2

true

MSS

2026-03-15T05:35:59.110552+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_532402

REC_0009143

Non-small cell lung cancer

Squamous cell carcinoma

IVA

None

25

5

73

female

3

36

4.7

2

carboplatin + paclitaxel + pembrolizumab

19.3

false

MSS

2026-03-15T05:35:59.110796+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_244723

REC_0009144

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR exon 19 deletion

24

9.9

67

female

0

5

5.5

2

osimertinib 80 mg daily

24

true

MSS

2026-03-15T05:35:59.111034+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_279316

REC_0009145

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

21

9.8

70

female

3

23

4.3

6

alectinib 600 mg BID

16.3

true

MSS

2026-03-15T05:35:59.111265+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_356552

REC_0009146

Non-small cell lung cancer

Adenocarcinoma

IVA

ALK fusion

28

14.6

72

female

2

4

7.5

0

alectinib 600 mg BID

22.2

false

MSI-H

2026-03-15T05:35:59.111510+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_986064

REC_0009147

Non-small cell lung cancer

Adenocarcinoma

IVA

KRAS G12C

23

16.9

55

male

1

17

4.6

2

sotorasib 960 mg daily

15.6

false

MSS

2026-03-15T05:35:59.111749+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_280848

REC_0009148

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

21

17.2

66

female

1

9

5.4

3

osimertinib 80 mg daily

8.2

true

MSI-H

2026-03-15T05:35:59.111986+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_948734

REC_0009149

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

25

16.7

73

female

1

14

6.5

6

sotorasib 960 mg daily

9.7

false

MSS

2026-03-15T05:35:59.112269+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_674017

REC_0009150

Non-small cell lung cancer

Large cell carcinoma

IVB

None (PD-L1 high)

21

4.7

56

female

1

20

6.3

4

pembrolizumab 200 mg q3w

17.7

true

MSS

2026-03-15T05:35:59.112509+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_282664

REC_0009151

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

19

11.7

63

female

1

6

5.7

5

sotorasib 960 mg daily

11

false

MSS

2026-03-15T05:35:59.112758+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_970529

REC_0009152

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

18

9.1

73

female

1

12

4.6

6

osimertinib 80 mg daily

4

true

MSS

2026-03-15T05:35:59.112994+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_545277

REC_0009153

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None (PD-L1 high)

31

5.3

42

male

0

57

5

6

pembrolizumab 200 mg q3w

11.4

false

MSS

2026-03-15T05:35:59.113372+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_684735

REC_0009154

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

27

4.8

60

male

0

9

4.8

6

sotorasib 960 mg daily

11.5

false

MSS

2026-03-15T05:35:59.113629+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_594716

REC_0009155

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None

25

4.7

68

female

0

67

5

6

carboplatin + paclitaxel + pembrolizumab

13.3

false

MSS

2026-03-15T05:35:59.113862+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_535230

REC_0009156

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

31

4.5

59

male

1

11

5.4

6

osimertinib 80 mg daily

18.2

false

MSS

2026-03-15T05:35:59.114108+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_287509

REC_0009157

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR exon 19 deletion

28

7.7

67

female

1

3

5.9

2

osimertinib 80 mg daily

16.6

true

MSS

2026-03-15T05:35:59.114347+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_973602

REC_0009158

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

19

19.4

70

male

2

20

5.8

5

alectinib 600 mg BID

11.9

false

MSI-H

2026-03-15T05:35:59.114597+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_952640

REC_0009159

Non-small cell lung cancer

Adenocarcinoma

IVA

KRAS G12C

19

15.7

61

female

1

12

4.9

2

sotorasib 960 mg daily

34.8

false

MSS

2026-03-15T05:35:59.114852+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_379377

REC_0009160

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

20

13.8

65

male

0

20

6

4

osimertinib 80 mg daily

8.3

false

MSI-H

2026-03-15T05:35:59.115097+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_386745

REC_0009161

Non-small cell lung cancer

Adenocarcinoma

IVA

ROS1 fusion

28

5.5

63

female

0

18

3.9

1

entrectinib 600 mg daily

15.4

false

MSS

2026-03-15T05:35:59.115346+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_703109

REC_0009162

Non-small cell lung cancer

Adenocarcinoma

III

EGFR exon 19 deletion

22

11.4

77

female

3

14

5

0

osimertinib 80 mg daily

19.2

false

MSI-H

2026-03-15T05:35:59.115591+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_242857

REC_0009163

Non-small cell lung cancer

Adenocarcinoma

IVA

ROS1 fusion

26

14

63

male

1

28

5.7

2

entrectinib 600 mg daily

12.2

false

MSS

2026-03-15T05:35:59.115833+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_529230

REC_0009164

Non-small cell lung cancer

Adenocarcinoma

IVA

ROS1 fusion

28

12.9

71

female

1

20

6.7

2

entrectinib 600 mg daily

20.1

false

MSI-H

2026-03-15T05:35:59.116125+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_775751

REC_0009165

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR L858R

29

10.3

75

female

1

10

5.9

8

osimertinib 80 mg daily

5.9

true

MSI-H

2026-03-15T05:35:59.116381+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_359261

REC_0009166

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

18

5.8

66

female

0

16

5.4

5

sotorasib 960 mg daily

10

true

MSS

2026-03-15T05:35:59.116745+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_187311

REC_0009167

Non-small cell lung cancer

Adenocarcinoma

IVA

ALK fusion

17

16.7

65

male

0

4

6.4

2

alectinib 600 mg BID

11.3

false

MSI-H

2026-03-15T05:35:59.116995+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_824359

REC_0009168

Non-small cell lung cancer

Large cell carcinoma

IVA

None (PD-L1 high)

20

5.4

69

male

0

14

6.2

1

pembrolizumab 200 mg q3w

18.6

false

MSS

2026-03-15T05:35:59.117234+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_926704

REC_0009169

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR exon 19 deletion

21

15

73

female

2

17

4.8

1

osimertinib 80 mg daily

20.2

false

MSI-H

2026-03-15T05:35:59.117487+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_292031

REC_0009170

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

18

16.2

72

female

2

21

5.6

7

entrectinib 600 mg daily

4.1

true

MSS

2026-03-15T05:35:59.117730+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_392599

REC_0009171

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

29

18.7

67

female

0

4

4.5

5

entrectinib 600 mg daily

6

true

MSS

2026-03-15T05:35:59.117973+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_625225

REC_0009172

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

31

13.4

86

male

1

6

5.7

4

sotorasib 960 mg daily

13.5

true

MSS

2026-03-15T05:35:59.118213+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_927470

REC_0009173

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

25

12.8

68

female

0

16

4.4

8

sotorasib 960 mg daily

13.3

true

MSI-H

2026-03-15T05:35:59.118448+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_967024

REC_0009174

Non-small cell lung cancer

Adenocarcinoma

IVB

None (PD-L1 high)

32

8.8

75

female

2

16

5.6

5

pembrolizumab 200 mg q3w

9.2

false

MSS

2026-03-15T05:35:59.118676+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_337319

REC_0009175

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR L858R

26

15.1

67

male

0

18

6.1

2

osimertinib 80 mg daily

20.6

true

MSS

2026-03-15T05:35:59.118919+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_902198

REC_0009176

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR L858R

29

4

73

female

2

24

6.5

2

osimertinib 80 mg daily

19.5

true

MSS

2026-03-15T05:35:59.119157+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_591818

REC_0009177

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

24

13.7

75

female

1

12

5.5

5

sotorasib 960 mg daily

13.5

false

MSS

2026-03-15T05:35:59.119396+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_399930

REC_0009178

Non-small cell lung cancer

Adenocarcinoma

IVA

ALK fusion

20

10.9

67

female

0

19

6

2

alectinib 600 mg BID

25.4

true

MSI-H

2026-03-15T05:35:59.119635+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_352839

REC_0009179

Non-small cell lung cancer

Squamous cell carcinoma

IVB

None (PD-L1 high)

19

3.8

66

female

1

21

6.8

3

pembrolizumab 200 mg q3w

16.6

true

MSS

2026-03-15T05:35:59.119963+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_677324

REC_0009180

Non-small cell lung cancer

Adenocarcinoma

IVA

ROS1 fusion

26

7.3

77

female

2

19

5.4

2

entrectinib 600 mg daily

25

false

MSS

2026-03-15T05:35:59.120248+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_229694

REC_0009181

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

28

9.4

47

female

0

17

4

alectinib 600 mg BID

16

false

MSS

2026-03-15T05:35:59.120487+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_207632

REC_0009182

Non-small cell lung cancer

Adenocarcinoma

III

KRAS G12C

18

19

60

male

1

5

7.9

0

sotorasib 960 mg daily

35.3

false

MSI-H

2026-03-15T05:35:59.120722+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_823729

REC_0009183

Non-small cell lung cancer

Adenocarcinoma

IVA

EGFR exon 19 deletion

28

14.1

74

female

2

20

5.2

2

osimertinib 80 mg daily

9.3

false

MSI-H

2026-03-15T05:35:59.120956+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_514307

REC_0009184

Non-small cell lung cancer

Adenocarcinoma

IVB

EGFR exon 19 deletion

18

9.4

72

female

1

10

5.8

4

osimertinib 80 mg daily

6.9

false

MSS

2026-03-15T05:35:59.121196+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_897417

REC_0009185

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

24

12.5

73

female

3

21

4.6

5

sotorasib 960 mg daily

15.3

false

MSS

2026-03-15T05:35:59.121436+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_101132

REC_0009186

Non-small cell lung cancer

Adenocarcinoma

IVB

ALK fusion

19

12.5

68

female

1

22

5.4

9

alectinib 600 mg BID

11.6

false

MSS

2026-03-15T05:35:59.121669+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_280195

REC_0009187

Non-small cell lung cancer

Large cell carcinoma

IVB

None (PD-L1 high)

31

5.9

73

female

2

25

5.1

4

pembrolizumab 200 mg q3w

6.2

false

MSS

2026-03-15T05:35:59.121897+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_342946

REC_0009188

Non-small cell lung cancer

Squamous cell carcinoma

IVA

None

25

5.3

67

female

1

5

4.7

2

carboplatin + paclitaxel + pembrolizumab

16.3

false

MSS

2026-03-15T05:35:59.122131+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_661196

REC_0009189

Non-small cell lung cancer

Large cell carcinoma

IVB

None (PD-L1 high)

24

5.2

69

male

0

7

6.8

8

pembrolizumab 200 mg q3w

13.2

false

MSS

2026-03-15T05:35:59.122367+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_149255

REC_0009190

Non-small cell lung cancer

Adenocarcinoma

IVA

KRAS G12C

31

7.9

64

male

1

16

5.4

1

sotorasib 960 mg daily

22.4

false

MSS

2026-03-15T05:35:59.122601+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_328334

REC_0009191

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

20

13

64

female

1

13

5.7

5

sotorasib 960 mg daily

8.6

true

MSI-H

2026-03-15T05:35:59.122844+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_113033

REC_0009192

Non-small cell lung cancer

Adenocarcinoma

IVA

ALK fusion

34

4.9

58

male

0

17

5.4

1

alectinib 600 mg BID

28.3

false

MSS

2026-03-15T05:35:59.123159+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_604001

REC_0009193

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

22

10.6

67

female

0

18

4.2

8

entrectinib 600 mg daily

11.9

true

MSS

2026-03-15T05:35:59.123405+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_634434

REC_0009194

Non-small cell lung cancer

Adenocarcinoma

IVA

ROS1 fusion

24

4.5

61

male

1

13

4.2

2

entrectinib 600 mg daily

19.6

true

MSS

2026-03-15T05:35:59.123646+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_994807

REC_0009195

Non-small cell lung cancer

Adenocarcinoma

III

EGFR exon 19 deletion

28

15.3

57

female

1

23

7.4

0

osimertinib 80 mg daily

40.9

true

MSI-H

2026-03-15T05:35:59.123897+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_636650

REC_0009196

Non-small cell lung cancer

Adenocarcinoma

IVB

ROS1 fusion

31

13.2

68

male

0

11

6.1

6

entrectinib 600 mg daily

10.5

false

MSI-H

2026-03-15T05:35:59.124192+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_986416

REC_0009197

Non-small cell lung cancer

Large cell carcinoma

IVB

None (PD-L1 high)

21

4.9

64

female

1

4

6.1

8

pembrolizumab 200 mg q3w

12

false

MSS

2026-03-15T05:35:59.124458+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_475068

REC_0009198

Non-small cell lung cancer

Adenocarcinoma

IVB

None (PD-L1 high)

20

15.8

57

female

0

27

6.1

8

pembrolizumab 200 mg q3w

16.3

true

MSS

2026-03-15T05:35:59.124711+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_609313

REC_0009199

Non-small cell lung cancer

Adenocarcinoma

IVA

KRAS G12C

24

16.5

82

female

2

11

5.9

1

sotorasib 960 mg daily

22.9

true

MSS

2026-03-15T05:35:59.124953+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)

ANODE_452052

REC_0009200

Non-small cell lung cancer

Adenocarcinoma

IVB

KRAS G12C

22

14.7

77

male

2

21

6.7

6

sotorasib 960 mg daily

16.9

false

MSS

2026-03-15T05:35:59.125193+00:00

Grok-4 high-fidelity EHR/Genomics simulator v2025.2 (Gaussian noise applied)